| Name | Title | Contact Details |
|---|
A pioneer in immuno-modulation by cell specific delivery of oligonucleotide drugs to antigen presenting cells completing IND enabling studies for a groundbreaking anti-GVHD drug for hematopoietic stem cell transplantation in hematological cancers.
Making advanced diagnostics and adoptive cell therapies more accessible by working from the bottom up via synthetic cells.
Leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer.
VGXI is a Spring, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Center for Functional Genomics is a Rensselaer, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.